Affection Animal Pharmaceuticals Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C1

  • Latest Deal Amount
  • $13.7M

  • Investors
  • 12

Affection Animal Pharmaceuticals General Information

Description

Developer of pet vaccines intended to enhance pet health condition. The company's products include veterinary biological products and veterinary chemical drugs, enabling pet families to protect pets from serious diseases.

Contact Information

Formerly Known As
Advaccine animal, Suzhou Advaccine Animal Pharmaceutical Co., Ltd., Advaccine animal medicine, Advaccine Animal Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Second Floor, Room 101, Building 1
  • No. 19 Yong'an Road
  • Suzhou, Jiangsu 215123
  • China
+86 0512
Primary Industry
Other Commercial Products
Vertical(s)
Corporate Office
  • Second Floor, Room 101, Building 1
  • No. 19 Yong'an Road
  • Suzhou, Jiangsu 215123
  • China
+86 0512

Affection Animal Pharmaceuticals Timeline

2022202320242025
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Affection Animal Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C1) 01-Jan-2025 $13.7M Completed Clinical Trials - General
4. Later Stage VC (Series C) 19-Feb-2024 Completed Clinical Trials - General
3. Early Stage VC (Series B) 29-Sep-2022 Completed Clinical Trials - General
2. Early Stage VC 12-Oct-2021 Completed Clinical Trials - General
1. Early Stage VC 05-Nov-2020 Completed Clinical Trials - General
To view Affection Animal Pharmaceuticals’s complete valuation and funding history, request access »

Affection Animal Pharmaceuticals Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDIB Capital International PE/Buyout Minority
Fosun Health Capital Corporate Venture Capital Minority
Suzhou Guofa Venture Capital Venture Capital Minority
GSR United Capital Venture Capital Minority
Haihe River Industry Fund Fund of Funds Minority
You’re viewing 5 of 12 investors. Get the full list »

Affection Animal Pharmaceuticals FAQs

  • When was Affection Animal Pharmaceuticals founded?

    Affection Animal Pharmaceuticals was founded in 2018.

  • Where is Affection Animal Pharmaceuticals headquartered?

    Affection Animal Pharmaceuticals is headquartered in Suzhou, China.

  • What industry is Affection Animal Pharmaceuticals in?

    Affection Animal Pharmaceuticals’s primary industry is Other Commercial Products.

  • Is Affection Animal Pharmaceuticals a private or public company?

    Affection Animal Pharmaceuticals is a Private company.

  • What is Affection Animal Pharmaceuticals’s current revenue?

    The current revenue for Affection Animal Pharmaceuticals is .

  • How much funding has Affection Animal Pharmaceuticals raised over time?

    Affection Animal Pharmaceuticals has raised $43.7M.

  • Who are Affection Animal Pharmaceuticals’s investors?

    CDIB Capital International, Fosun Health Capital, Suzhou Guofa Venture Capital, GSR United Capital, and Haihe River Industry Fund are 5 of 12 investors who have invested in Affection Animal Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »